Healthcare & Life Sciences
Cernostics
United States
acquiredacquired
acquired
Stage
3
Investors
About
Cernostics develops spatial biology diagnostics for clinical applications, enabling advanced tissue-based analysis to improve disease diagnosis and treatment.
Explore Cernostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.